Skip to content

Avalo Therapeutics AVTX Cash payable to tax authorities related to withholding shares to satisfy RSU withholding obligations

Cash payable to tax authorities related to withholding shares to satisfy RSU withholding obligations at other companies

Allient Inc. logo
Allient Inc.ALNT
$18K-71.4%
Liberty Energy logo
Liberty EnergyLBRT
$0-100%
ACV Auctions Inc. logo
ACV Auctions Inc.ACVA
$6.72M-1.0%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$6.92M+12.6%
CarGurus, Inc. logo
CarGurus, Inc.CARG
$6.61M-26.4%
Kyverna Therapeutics, Inc. logo
Kyverna Therapeutics, Inc.KYTX
$189K

Other financials

Income statement

See full
Revenue$59.0K-69.3%
Gross profit$963.0K+8,855%
Operating income-$20.9M-42.5%
Net income-$19.6M-49.3%
EPS (diluted)-$0.98+21.6%

Balance sheet

See full
Cash & equivalents$25.3M-79.8%
Total debt$328.0K-59.1%
Total equity$68.3M-44.3%
Total assets$99.9M-27.9%

Cash flow

See full
Operating cash flow-$17.7M-87.1%
CapEx-
Free cash flow-$15.0M-444%

Valuation

See full
Market cap$946.18M+1,783%
Enterprise value$921.19M-1,342%
P/S1,892.4×+1,852×

Profitability

See full
Gross margin182%+176pp
Operating margin-15,536.1%-17,275pp
Net margin-7,965.8%-10,750pp
FCF margin-11,123.8%-13,374pp

Returns & leverage

See full
Return on equity-88.8%
Debt / equity0.0×
Current ratio7.7×-14.9×

Where this comes from

Reported directly by Avalo Therapeutics in its filing.

Tagged under the XBRL concept avtx:IssuanceOfCommonStockAndSeriesCPreferredStockPursuantToAcquisition.

The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's cash payable to tax authorities related to withholding shares to satisfy rsu withholding obligations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avalo Therapeutics's cash payable to tax authorities related to withholding shares to satisfy RSU withholding obligations?
Avalo Therapeutics (AVTX) reported cash payable to tax authorities related to withholding shares to satisfy RSU withholding obligations of $0 in Q1 2026.
How has Avalo Therapeutics's cash payable to tax authorities related to withholding shares to satisfy RSU withholding obligations changed year-over-year?
Avalo Therapeutics's cash payable to tax authorities related to withholding shares to satisfy RSU withholding obligations increased by 100.0% year-over-year, from -$509K to $0.
What does cash payable to tax authorities related to withholding shares to satisfy RSU withholding obligations mean?
Represents cash outflows related to tax withholding obligations incurred when the company settles restricted stock units or other equity-based compensation. The company pays these taxes on behalf of employees by withholding a portion of the shares that would otherwise be issued. This reflects the cash impact of equity-based compensation programs on the company's liquidity.